These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24872209)

  • 1. Plasma concentrations of tadalafil in children with pulmonary arterial hypertension.
    Kohno H; Ichida F; Hirono K; Ozawa S; Yoshimura N; Nakamura T; Akita C; Ishida K; Taguchi M
    Ther Drug Monit; 2014 Oct; 36(5):576-83. PubMed ID: 24872209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study.
    Oudiz RJ; Brundage BH; Galiè N; Ghofrani HA; Simonneau G; Botros FT; Chan M; Beardsworth A; Barst RJ;
    J Am Coll Cardiol; 2012 Aug; 60(8):768-74. PubMed ID: 22818063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
    Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of drugs for pediatric pulmonary hypertension.
    Nakau K; Sugimoto M; Oka H; Kajihama A; Maeda J; Yamagishi H; Kamiyama N; Tasaki Y; Kajino H; Azuma H
    Pediatr Int; 2016 Nov; 58(11):1112-1117. PubMed ID: 27038140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan.
    Faruqi S; Fathi H; Morice AH
    Int J Cardiol; 2010 Oct; 144(3):e43-5. PubMed ID: 19171388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
    Wrishko RE; Dingemanse J; Yu A; Darstein C; Phillips DL; Mitchell MI
    J Clin Pharmacol; 2008 May; 48(5):610-8. PubMed ID: 18305126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension.
    Arif SA; Poon H
    Clin Ther; 2011 Aug; 33(8):993-1004. PubMed ID: 21762988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension.
    Yokoyama Y; Tomatsuri M; Hayashi H; Hirai K; Ono Y; Yamada Y; Todoroki K; Toyo'oka T; Yamada H; Itoh K
    J Pharm Biomed Anal; 2014 Feb; 89():227-32. PubMed ID: 24309556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tadalafil population pharmacokinetics in patients with erectile dysfunction.
    Trocóniz IF; Tillmann C; Staab A; Rapado J; Forgue ST
    Eur J Clin Pharmacol; 2007 Jun; 63(6):583-90. PubMed ID: 17431603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.
    Barst RJ; Oudiz RJ; Beardsworth A; Brundage BH; Simonneau G; Ghofrani HA; Sundin DP; Galiè N;
    J Heart Lung Transplant; 2011 Jun; 30(6):632-43. PubMed ID: 21256048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and validated quantification of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, tadalafil, and 2 of their metabolites in human blood plasma by LC-MS/MS--application to forensic and therapeutic drug monitoring cases.
    Rust KY; Wilkens H; Kaiser R; Bregel D; Wilske J; Kraemer T
    Ther Drug Monit; 2012 Dec; 34(6):729-35. PubMed ID: 23128911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil.
    Levin YD; White RJ
    Drugs Today (Barc); 2011 Feb; 47(2):145-56. PubMed ID: 21431102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil for the treatment of pulmonary arterial hypertension.
    Klinger JR
    Expert Rev Respir Med; 2011 Jun; 5(3):315-28. PubMed ID: 21702653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil for the treatment of pulmonary arterial hypertension.
    Rosenzweig EB
    Expert Opin Pharmacother; 2010 Jan; 11(1):127-32. PubMed ID: 20001434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension.
    Barst RJ; Ivy D; Dingemanse J; Widlitz A; Schmitt K; Doran A; Bingaman D; Nguyen N; Gaitonde M; van Giersbergen PL
    Clin Pharmacol Ther; 2003 Apr; 73(4):372-82. PubMed ID: 12709727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model.
    Ferguson-Sells L; Velez de Mendizabal N; Li B; Small D
    Clin Pharmacokinet; 2022 Feb; 61(2):249-262. PubMed ID: 34379314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan Pharmacokinetics in Pediatric Patients with Pulmonary Arterial Hypertension: Comparison of Dried Blood Spot and Plasma Analysis.
    Géhin M; Sidharta PN; Dingemanse J
    Pharmacology; 2016; 98(3-4):111-4. PubMed ID: 27189212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension.
    Udeoji DU; Schwarz ER
    Ther Adv Respir Dis; 2013 Feb; 7(1):39-49. PubMed ID: 23129569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sildenafil in children with pulmonary arterial hypertension.
    Olguín HJ; Martínez HO; Pérez CF; Mendiola BR; Espinosa LR; Pacheco JLC; Pérez JF; Magaña IM
    World J Pediatr; 2017 Dec; 13(6):588-592. PubMed ID: 28791664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers.
    Spence R; Mandagere A; Harrison B; Dufton C; Boinpally R
    J Pharm Sci; 2009 Dec; 98(12):4962-74. PubMed ID: 19455620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.